BusinessScholar Rock Agrees to Transfer FDA Voucher to BioNTech for $205 MillionBy Helena WardNov 11, 2026, 6:45 PM UTC
BusinessBioNTech Spent $311.8 Million on ADS Buybacks in Third QuarterBy Helena WardNov 3, 2026, 3:16 PM UTC
HealthBioNTech, DualityBio Say Breast Cancer Trial Met Goal Amid Lung Disease CasesBy Naomi CalderOct 26, 2026, 9:30 AM UTC
HealthBioNTech Plans Pumitamig-Trodelvy Regimen in Breast Cancer TrialBy Naomi CalderOct 24, 2026, 1:47 AM UTC
HealthBioNTech Plans Trodelvy Combination in Global Phase 3 Breast Cancer TrialBy Naomi CalderOct 22, 2026, 7:35 PM UTC
